The proinflammatory phenotype of AIH is attributed to the differentiation into Th17 instead of Treg cells, and therapy that targets IL-17 increases regulatory cells from CD4+CD25− cells derived from AIH patients [210]. Here, CD4 is linked to autoimmune hepatitis.